Edition:
India

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

9.17CAD
8:04pm IST
Change (% chg)

$0.57 (+6.63%)
Prev Close
$8.60
Open
$8.94
Day's High
$9.25
Day's Low
$8.80
Volume
66,130
Avg. Vol
73,510
52-wk High
$10.47
52-wk Low
$6.44

Chart for

About

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead... (more)

Overall

Beta: 2.13
Market Cap(Mil.): $689.24
Shares Outstanding(Mil.): 83.54
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates